Additionally, due to the large differences in expression between the tumor groups, SST5 represents a potential new immunohistochemistry panel marker for PC in addition to the established markers parafibromin and Ki-67 and suggested markers galectin 3 and PGP9.5. Here, SSTR5 is linked to pachyonychia congenita.